數位疫苗市場規模、佔有率和成長分析（按類型、部署模式、最終用戶和地區）- 2025-2032 年產業預測

2023 年全球數位疫苗市場規模價值 20 億美元，預計將從 2024 年的 22.2 億美元成長到 2032 年的 50.3 億美元，預測期間（2025-2032 年）的複合年成長率為 10.8%。

數位疫苗是一種變革性的方法，透過神經認知訓練和推動技術改變行為模式，從而促進身心健康。這些工具採用虛擬實境、智慧型手機應用程式和人工智慧等先進的數位技術，旨在以經濟有效的方式培養積極的習慣並改善心理健康。醫療 IT 市場的快速擴張，以及物聯網、穿戴式科技、AR/VR 等技術創新，正在增強針對各種健康挑戰的頻繁行為介入的實施。美國國防部的虛擬 PTSD 體驗等措施展示了虛擬實境在心理健康護理領域的潛力。隨著人工智慧和機器學習推動引人注目的應用程式的發展，數位疫苗在促進更健康的生活方式方面顯示出希望，尤其是在年輕人中。此類創新對未來的影響是巨大且前景光明的。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 次要和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

數位疫苗市場規模（按類型和複合年成長率） (2025-2032)

• 市場概況
• 疫苗管理軟體
• 疫苗接種追蹤應用程式
• 數位平台

數位疫苗市場規模（按部署模式和複合年成長率） (2025-2032)

• 市場概況
• 雲端基礎
• 本地

數位疫苗市場規模（按最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫療保健提供者
• 製藥和生物技術公司
• 政府和公共衛生機構
• 研究機構和學術中心
• 患者和看護者

數位疫苗市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司詳細資訊
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Pfizer（US）
• Moderna（US）
• Johnson & Johnson（US）
• AstraZeneca（UK）
• Merck（US）
• Sanofi（France）
• GSK（UK）
• Novavax（US）
• BioNTech（Germany）
• Bharat Biotech（India）
• Microsoft（US）
• IBM（US）
• Oracle（US）
• Salesforce（US）
• Amazon（US）
• Google（US）
• McKesson（US）
• AmerisourceBergen（US）
• CVS Health（US）
• Walgreens Boots Alliance（US）

結論和建議

Global Digital Vaccine Market size was valued at USD 2.0 billion in 2023 and is poised to grow from USD 2.22 billion in 2024 to USD 5.03 billion by 2032, growing at a CAGR of 10.8% during the forecast period (2025-2032).

Digital vaccines represent a transformative approach to promoting mental and physical well-being by modifying behavioral patterns through neurocognitive training and nudging techniques. Utilizing advanced digital technologies such as virtual reality, smartphone apps, and artificial intelligence, these tools aim to foster positive habits and improve mental health affordably and effectively. The rapid expansion of the healthcare IT market, alongside innovations like the Internet of Things, wearable tech, and AR/VR, enhances the delivery of frequent behavioral interventions across various health challenges. Initiatives like the US Department of Defense's Virtual PTSD Experience exemplify the potential of virtual reality in mental health care. With AI and machine learning driving the development of engaging applications, digital vaccines hold promise in cultivating healthier lifestyles, particularly among youth. The future impact of these innovations is both vast and promising.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Vaccine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Vaccine Market Segments Analysis

Global Digital Vaccine Market is segmented by Type, Deployment mode, End user and region. Based on Type, the market is segmented into Vaccine management software, vaccination tracking applications and digital platforms. Based on Deployment mode, the market is segmented into Cloud-based and on-premise. Based on End user, the market is segmented into Healthcare providers, pharmaceutical & biotechnology companies, government & public health agencies, research institutes & academic centers and patients & caregivers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Vaccine Market

The Global Digital Vaccine market is being significantly driven by a growing emphasis on immunization programs from governments and healthcare organizations across the globe, aimed at curtailing the spread of infectious diseases. This increased focus has spurred a demand for digital vaccine solutions to boost the efficiency and effectiveness of vaccination initiatives. For instance, the World Health Organization's Global Vaccine Action Plan strives to enhance vaccination coverage while ensuring equitable access to vaccines. Digital tools, such as mobile applications for scheduling appointments and sending reminders, empower healthcare providers to better connect with target populations, ultimately leading to improved vaccination rates and health outcomes.

Restraints in the Global Digital Vaccine Market

The Global Digital Vaccine market faces significant constraints related to the collection, storage, and sharing of sensitive health data within digital vaccination systems, which raises important issues surrounding data privacy and security. Ensuring the protection of personal health information and confidentiality of vaccination records is vital. The absence of effective security measures could lead to data breaches and unauthorized access, which can undermine public trust. Therefore, it is imperative to address these privacy concerns and adopt stringent data protection protocols to foster confidence and promote the widespread acceptance and use of digital vaccine solutions in the market.

Market Trends of the Global Digital Vaccine Market

The Global Digital Vaccine market is experiencing a notable trend towards integrating blockchain technology to enhance the security and transparency of vaccine supply chains. As stakeholders increasingly seek to combat counterfeit products and ensure the integrity and proper handling of vaccines, blockchain's decentralized and tamper-resistant ledger system emerges as a robust solution. Initiatives such as IBM's "Blockchain for Vaccines" showcase the potential of this technology to track vaccines from manufacturer to patient, providing clear traceability and auditability. This shift not only addresses the pressing concerns of vaccine integrity but also bolsters consumer confidence and supports streamlined operations within the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Vaccine Market Size by Type & CAGR (2025-2032)

• Market Overview
• Vaccine management software
• vaccination tracking applications
• digital platforms

Global Digital Vaccine Market Size by Deployment mode & CAGR (2025-2032)

• Market Overview
• Cloud-based
• on-premise

Global Digital Vaccine Market Size by End user & CAGR (2025-2032)

• Market Overview
• Healthcare providers
• pharmaceutical & biotechnology companies
• government & public health agencies
• research institutes & academic centers
• patients & caregivers

Global Digital Vaccine Market Size & CAGR (2025-2032)

• North America (Type, Deployment mode, End user)
  • US
  • Canada
• Europe (Type, Deployment mode, End user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Deployment mode, End user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Deployment mode, End user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Deployment mode, End user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Pfizer (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Moderna (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AstraZeneca (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GSK (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novavax (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioNTech (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bharat Biotech (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microsoft (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBM (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oracle (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salesforce (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amazon (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Google (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• McKesson (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AmerisourceBergen (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CVS Health (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Walgreens Boots Alliance (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations